Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ: RARE · Real-Time Price · USD

25.00

-0.80 (-3.10%)

At close: May 15, 2026, 4:00 PM EDT

25.10

+0.10 (0.40%)

After-hours: May 15, 2026, 7:35 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America Revenue	378.46M	377.00M	340.46M
North America Revenue Growth	0.39%	10.73%	10.85%
Latin America Revenue	157.33M	170.00M	130.71M
Latin America Revenue Growth	-7.45%	30.06%	69.01%
Europe Revenue	115.28M	108.00M	80.12M
Europe Revenue Growth	6.74%	34.79%	68.56%
Asia-Pacific Revenue	18.35M	18.00M	8.93M
Asia-Pacific Revenue Growth	1.97%	101.57%	301.53%
Revenue (Other)	279.00K	-	-230.00K
Revenue (Total)	669.71M	673.00M	560.00M
Revenue (Total) Growth	-0.49%	20.18%	29.03%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Crysvita Revenue	167.73M	177.00M	134.71M
Crysvita Revenue Growth	-5.24%	31.39%	77.96%
Dojolvi Revenue	97.48M	96.00M	88.19M
Dojolvi Revenue Growth	1.54%	8.85%	24.86%
Evkeeza Revenue	66.29M	59.00M	32.16M
Evkeeza Revenue Growth	12.36%	83.45%	783.09%
Mepsevii Revenue	35.31M	37.00M	30.35M
Mepsevii Revenue Growth	-4.57%	21.91%	-0.30%
Total Product Revenue	366.81M	369.00M	285.42M
Total Product Revenue Growth	-0.59%	29.29%	58.20%
Crysvita Royalty Revenue	302.62M	304.00M	274.82M
Crysvita Royalty Revenue Growth	-0.45%	10.62%	50.46%
Revenue (Other)	279.00K	-	-230.00K
Revenue (Total)	669.71M	673.00M	560.00M
Revenue (Total) Growth	-0.49%	20.18%	29.03%

Updated May 5, 2026. Data Source: Fiscal.ai.